Article info
PDFClinical and epidemiological research
Extended report
Low immunogenicity of tocilizumab in patients with rheumatoid arthritis
- Correspondence to Dr Mark C Genovese, Division of Immunology and Rheumatology, Stanford University Medical Center, 900 Blake Wilbur Drive, Palo Alto, CA 94305, USA; genovese{at}stanford.edu
Citation
Low immunogenicity of tocilizumab in patients with rheumatoid arthritis
Publication history
- Received August 1, 2016
- Revised November 22, 2016
- Accepted November 26, 2016
- First published December 22, 2016.
Online issue publication
October 31, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/